Vitality Re VIII Ltd Series 2017-1

Share

Aetna closes $200m Vitality Re IX health insurance-linked securities deal

Health care benefits insurer Aetna has successfully completed its ninth capital markets backed reinsurance arrangement through a $200 million issuance of health insurance-linked securities (ILS), in the Vitality Re IX Ltd. (Series 2018-1) transaction.The issuance was completed using newly established Cayman Islands special purpose vehicle Vitality Re IX Ltd. which read the full article →

Vitality Re IX health ILS from Aetna priced below guidance

The $200 million Vitality Re IX Ltd. (Series 2018-1) health insurance-linked securities (ILS) transaction from Aetna has now been priced and both tranches of notes have had their coupons fixed at levels below the bottom-end of the initial price guidance ranges.The Vitality Re series of health insurance ILS transactions are read the full article →

Vitality Re IX pricing delayed on health insurer fee uncertainty

Pricing for the in-the-market $200 million Vitality Re IX Ltd. (Series 2018-1) health insurance-linked securities (ILS) issuance has been delayed due to uncertainty over the future of health insurer fees, because the U.S. government has been considering the fees as part of government shutdown related budgetary debates.The so-called anti-shutdown bill, read the full article →

Vitality Re IX $200m health ILS from Aetna the first deal of 2018

A new health insurance-linked securities (ILS) transaction from Aetna is the first cat bond or ILS transaction to launch and be listed in our Deal Directory in 2018, with a $200 million Vitality Re IX Ltd. (Series 2018-1) that will secure reinsurance protection against a deterioration of the insurers' medical read the full article →

Aetna hails how eighth Vitality Re ILS enhances its capital position

Health insurance company Aetna said that its successful eighth Vitality Re health insurance linked securitisation transaction, the $200 million Vitality Re VIII Ltd. (Series 2017-1), contributes to an enhanced capital position for the firm.The successful execution of the Vitality Re VIII transaction, and sale of the notes issued to investors, now read the full article →

Vitality Re VIII health ILS prices at low end of guidance for Aetna

Aetna's latest and eighth medical benefit claims insurance-linked security (ILS) transaction, Vitality Re VIII Ltd. (Series 2017-1), has now been priced at the low end of coupon guidance, once again reflecting investor demand for these very remote health insurance related risks.Aetna has consistently seen its Vitality Re ILS transactions, where read the full article →

Aetna launches $200m Vitality Re VIII health insurance linked ILS

Health insurance giant Aetna has returned to the insurance-linked securities (ILS) market for its eighth Vitality Re transaction, launching a Vitality Re VIII Ltd. (Series 2017-1) deal that seeks $200 million of reinsurance cover against a deterioration of its medical benefit ratio.Vitality Re VIII Limited is a newly formed Cayman read the full article →